Cardiac amyloidosis is associated with systemic amyloidosis and patients usually presents with symptoms of congestive heart failure and echocardiographic evidence of restrictive cardiomyopathy. The disease progresses rapidly, and the prognosis is usually poor because patients often present with nonspecific signs and symptoms, which can delay an accurate diagnosis. Although cardiac arrest due to ventricular arrhythmias is responsible in some cases, ventricular arrhythmias in cardiac amyloidosis are uncommon. The present report describes an unusual case of a 52-year-old woman who had been diagnosed as having multiple myeloma and presented with a long QT interval and polymorphic ventricular tachycardia. These findings may be associated with disease activity.
Introduction
Systemic amyloid light chain (AL) amyloidosis (previously known as primary amyloidosis) is a multisystem disease characterized by the extracellular deposition of fibrils composed of immunoglobulin light chains within various organs. AL amyloidosis is associated with different types of monoclonal plasma cell dyscrasias, including multiple myeloma and other monoclonal gammopathies. 1 Cardiac involvement is clinically reported in approximately one-half of all cases, but the heart is affected pathologically in up to 90% AL amyloidosis patients. 2, 3 Patients with cardiac amyloidosis can present a wide spectrum of clinical manifestations, but usually have symptoms of congestive heart failure and echocardiographic evidence of restrictive cardiomyopathy. The present report describes an unusual case of multiple myeloma-associated cardiac amyloidosis in a patient who presented a long QT interval (QTc) and polymorphic ventricular tachycardia (VT).
Case
A 52-year-old woman was admitted to the hospital owing to exertional dyspnea with atypical chest discomfort. She had been well previously and had no prior cardiovascular disease or were maintained at 90 to 110 beats/min. After short-term use of temporary pacing, isoproterenol was administered intravenously and its dosage was titrated to maintained basal heart rate above 60 beats/min. With the second cycle of chemotherapy for myeloma, she had no recurrent polymorphic VT, even though the QTc remained at 504 msec.
Discussion
Amyloidosis usually involves more than one organ system, in which anti-parallel β-pleated sheets of amyloid fibrils are deposited. AL amyloidosis is the most common form that causes cardiac amyloidosis in patients with plasma cell myeloma, as in this report. 4 Cardiac amyloidosis is common in patients with AL amyloidosis. Infiltration of the heart by amyloid proteins results in biventricular wall thickening, resulting in restrictive cardiomyopathy that manifests at a later stage with heart failure and conduction abnormalities.
5
Cardiac amyloidosis should be suspected in any patient who presents with heart-failure symptoms, low ECG voltage, and a restrictive filling pattern or ventricular hypertrophy on echocardiography. 2 The disease progresses rapidly, and the prognosis is usually poor because patients often present with nonspecific signs and symptoms that prolong the time to diagnosis. Up to 30% patients die suddenly because of pulseless electrical activity or electromechanical dissociation. 6, 7 Although cardiac arrest due to ventricular arrhythmias is responsible in some cases, 8 
A B
Prolonged QT and polymorphic VT in cardiac amyloidosis
